Muscle Stimulation Devices Market Driven By Rising Geriatric Population
- Ronak Shah
- U.S.A
- January 23, 2025

The muscle stimulation devices market is estimated to be valued at US$ 756.7 Mn in 2024 and is expected to exhibit a CAGR of 3.8% over the forecast period 2023- 2030, as highlighted in a new report published by Coherent Market Insights’ The muscle stimulation devices market is primarily driven by the rising geriatric population globally.
As per the United Nations Population Fund, the number of people aged 60 years or above is projected to double from 962 million globally in 2017 to 2.1 billion by 2050. Growing age is accompanied with mobility issues and muscle weakness. This has led to an increase in demand for muscle stimulation devices for muscle rehabilitation and recovery post injuries or surgeries in the aged population. Further, growing popularity of home-based muscle stimulation devices is also fueling market growth owing to convenience and cost-effectiveness.
Key Market Trends: Transcutaneous electrical nerve stimulation (TENS) devices are witnessing high demand in recent years owing to benefits such as pain relief, increased blood circulation, and relaxation of muscles without the need for medications. Neuromuscular electrical stimulation (NMES) devices are also gaining traction in the market and are expected to exhibit lucrative growth over the forecast period. NMES devices help in strengthening weak or injured muscles and improve mobility by replicating muscle contractions.
Muscle Stimulation Devices Market Opportunities: Neuromuscular Rehabilitation Segment: Neuromuscular rehabilitation devices accounted for over 35% of global muscle stimulation devices market share in 2023. These devices help in rehabilitation of muscles affected by conditions like strokes, spinal cord injuries and other neuromuscular disorders. With rising cases of strokes and other injuries globally, the demand for these devices is expected to increase significantly during the forecast period. New technologies enabling home-based rehabilitation are further expanding opportunities in this segment.
Sports Injury Treatment Segment: These devices are widely used for treating muscle fatigue, soreness and injuries in athletes and regular gym-goers. The devices help strengthen muscles, accelerate muscle recovery from strains and tears and improve sports performance over time. Several sports clubs and physiotherapy centers have started offering muscle stimulation services. Growing health awareness and increasing sports participation worldwide is fueling demand. Portable devices for personal use have also boosted market prospects in recent years.
Key Market Takeaways: The global muscle stimulation devices market is anticipated to witness a CAGR of 3.8% during the forecast period 2023-2030, owing to growing geriatric population and rising incidence of chronic pain and neuromuscular disorders.
On the basis of product type, neuromuscular electrical stimulation (NMES) devices segment is expected to hold a dominant position, owing to wide application in rehabilitation, pain management and sports medicine.
By application, neuromuscular rehabilitation segment is projected to be the largest revenue generating segment over the forecast period due to increased cases of strokes and injuries.
On the basis of region, North America is expected to hold a dominant position over the forecast period, due to presence of major players, higher healthcare spending and growing adoption of muscle stimulation therapy.
Competitor Insights: Key players operating in the muscle stimulation devices market include Zynex Inc., Baptist Health, DJO Global, Inc. (Colfax), NeuroMetrix, and Guangzhou Longest Science & Technology. These players are focusing on new product launches and geographic expansion to strengthen their market position.
Recent Developments: In August 2023, DJO Global launched the GameReady GRX system, touted as the most advanced cold therapy and compression device for post-operative recovery and injury rehabilitation. The system combines dynamic compression therapy with cryotherapy to reduce pain and swelling. More information in full report.